ADVFN US – Market Content Editor
-

Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Futures Mixed as Google Sidesteps Major Antitrust Penalties
U.S. stock futures indicate a mixed start on Wall Street after equities dropped in the previous session. Alphabet avoided the threat of severe sanctions in a high-profile antitrust case, with a federal judge ruling that Google does not need to divest its popular Chrome browser. Meanwhile, investors await the Federal Reserve’s latest economic report, Salesforce…
-

Gold Tops $3,500 Briefly as Fiscal Risks and Trade Tensions Drive Safe-Haven Demand
Gold prices in Asian trading on Wednesday briefly climbed above $3,500 an ounce, hitting record levels as investors sought refuge amid ongoing concerns over global fiscal health and uncertainty around U.S. trade tariffs. However, the dollar’s recovery, fueled by global bond market selloffs, capped further gains in the yellow metal. Spot gold traded at $3,534.61…
-

Oil Holds Near One-Month High as US-Iran Sanctions and OPEC+ Loom
Oil prices stayed near a one-month peak in early Asian trading on Wednesday, following fresh U.S. sanctions on Iran’s oil sector that fueled concerns over tighter supply. Market attention is now turning to the upcoming OPEC+ meeting, where the cartel is expected to maintain current production levels after a series of hikes earlier this year.…
-

U.S. Stocks Close Mostly Lower But Well Off Worst Levels
After initially showing a significant move to the downside, stocks regained some ground over the course of the trading day on Tuesday but remained firmly negative. The major averages all moved notably lower, extending the pullback seen during last Friday’s session. The tech-heavy Nasdaq slumped 175.92 points or 0.8 percent to 21,279.63 but had tumbled…
-

Actelis Networks Stock Jumps After $0.5 Million FAA Contract
Actelis Networks Inc (NASDAQ:ASNS) shares surged 42% Tuesday after the company announced it had secured a $0.5 million contract from the Federal Aviation Administration (FAA) to supply advanced hybrid-fiber networking solutions for the modernization of critical air traffic control systems. The order is part of the FAA’s larger infrastructure upgrade program, following Congress’s approval of…
-

Zymeworks Shares Drop After Halting Development of Cancer Therapy
Zymeworks Inc (NASDAQ:ZYME) stock declined 9.1% in premarket trading Tuesday after the clinical-stage biotech company announced it will voluntarily cease clinical development of ZW171, a T cell engager aimed at treating gynecological, thoracic, and digestive system cancers. The decision followed the completion of the planned cohorts in the dose-escalation phase of the Phase 1 trial…
-

Ideaya Biosciences Shares Jump Following $210 Million Licensing Deal with Servier
Ideaya Biosciences Inc (NASDAQ:IDYA) saw its stock climb 6.9% in premarket trading on Tuesday after announcing an exclusive licensing agreement with French pharmaceutical company Servier for its eye cancer therapy, darovasertib. Under the agreement, Servier will gain regulatory and commercial rights for darovasertib in all territories outside the United States, while Ideaya retains U.S. rights.…
-

SHF Holdings Shares Surge After Launching Full-Service Cannabis Banking Program
SHF Holdings Inc (NASDAQ:SHFS) stock jumped 70% in premarket trading on Tuesday after unveiling its Fully Managed Cannabis Banking Program, a first-of-its-kind solution providing end-to-end operational and compliance outsourcing for financial institutions serving the cannabis industry. The program enables banks and credit unions to handle cannabis-related deposits without expanding internal teams or assuming additional regulatory…
-

Amarin Shares Rise on ESC Congress Data Highlighting VASCEPA Mechanism
Shares of Amarin Corporation PLC (NASDAQ:AMRN) increased 3.1% in premarket trading after the company presented new in vitro data at the European Society of Cardiology Congress 2025 showing potential anti-inflammatory mechanisms of its drug VASCEPA/VAZKEPA. The research highlighted how eicosapentaenoic acid (EPA), VASCEPA’s active ingredient, may help reduce inflammation in atherosclerotic cardiovascular disease (ASCVD) by…
-

TNF Pharmaceuticals Shares Rise After Gaining Exclusive Crypto Computing Rights
Shares of TNF Pharmaceuticals (NASDAQ:TNFA) climbed 5% following the announcement that the company has secured exclusive global rights to a pioneering light-based computing accelerator for cryptocurrency applications. The company entered into a licensing agreement with LightSolver Ltd. for its laser-based processing unit (LPU) technology, designed to execute compute-intensive operations far faster than conventional GPUs and…